#12951 on the rich list of 14,452 insiders
Errol B. Desouza
Director at Royalty Pharma; Director at Alector; Director at Korsana Biosciences. Based in South San Francisco, California.
$5.9M
in disclosed stock, −$95K (−1.58%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 12951st of 14,452
- Companies held
- 3
- Largest holding
- RPRX, 93.6% of total
- Latest SEC filing
- Jun 17, 2026
What the $5.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Royalty Pharma RPRX Class A Ordinary Shares | Directly | 81,352 | $67.72 | $5.5M | 93.6% | Form 4, May 13, 2025 |
| Alector ALEC Common Stock | Directly | 98,650 | $2.30 | $227K | 3.9% | Form 4, Jun 17, 2026 |
| Korsana Biosciences KRSA Common Stock | Directly | 4,286 split-adjusted | $35.45 | $152K | 2.6% | Form 4, Nov 30, 2023 |
Share counts are the amounts Errol B. Desouza reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12948 | Matthew Black Sr VP Chief Tax Officer, Waste Connections. The Woodlands, TX | $5.9M |
| 12949 | Michael T. Dan Director, Principal Financial Group. Des Moines, IA | $5.9M |
| 12950 | Roxanne M. Martino Director, Ventas. Chicago, IL | $5.9M |
| 12951 | Errol B. Desouza Director, Royalty Pharma. South San Francisco, CA | $5.9M |
| 12952 | Christopher B. Harned Director, Quad/Graphics. Sussex, WI | $5.9M |
| 12953 | Carly D. Brantz Chief Marketing Officer, DigitalOcean Holdings. New York, NY | $5.9M |
| 12954 | Dave Schaeffer CHAIRMAN, CEO, AND PRESIDENT, Cogent Communications Holdings. Washington, DC | $5.9M |
Other Royalty Pharma insiders
All RPRX insiders- Pablo G. Legorreta$335MCEO, Chairman of the Board. #516 overall
- George W. Lloyd$184MEVP, Investments & CLO. #939 overall
- Terrance P. Coyne$132MEVP & CFO. #1225 overall
- James F. Reddoch$57.3MEVP & Chief Scientific Officer. #2308 overall
- Rory B. Riggs$28.5MDirector. #2664 overall
- Christopher Hite$13.6MEVP & Chairman, Partnering. #6962 overall
Questions
How much stock does Errol B. Desouza own?
Errol B. Desouza holds $5,887,981 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 12951st on the Stock Rich List.
Is this Errol B. Desouza's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.